Literature DB >> 19463399

Clinical significance of post-procedural TIMI flow in patients with cardiogenic shock undergoing primary percutaneous coronary intervention.

Rajendra H Mehta1, Fang-Shu Ou, Eric D Peterson, Richard E Shaw, William B Hillegass, John S Rumsfeld, Matthew T Roe.   

Abstract

OBJECTIVES: We sought to evaluate the impact of post-primary percutaneous coronary intervention (PCI) Thrombolysis In Myocardial Infarction (TIMI) flow grades in the infarct-related artery (IRA) in patients with ST-segment elevation myocardial infarction (STEMI) and cardiogenic shock.
BACKGROUND: The clinical implications and correlates of post-procedural TIMI flow grades in patients with STEMI and cardiogenic shock treated with primary PCI have not been elucidated.
METHODS: We evaluated 4,731 STEMI patients with cardiogenic shock undergoing primary PCI at 567 hospitals participating in the American College of Cardiology-National Cardiovascular Database CathPCI Registry to determine the association of post-procedural TIMI flow grades 0 to 2 with in-hospital outcomes.
RESULTS: Post-PCI TIMI flow grades 0 to 2 in the IRA were present in 14.7% of patients. Compared with patients with TIMI flow grade 3, those with TIMI flow grades 0 to 2 were more likely to undergo coronary artery bypass graft surgery after PCI (20% vs. 5.4%), and develop renal failure (10.1% vs. 5.1%), cardiac tamponade (1.0% vs. 0.5%), and bleeding requiring blood transfusion (35.2% vs. 21.6%). Unadjusted mortality was more than 2-fold higher with TIMI flow grades 0 to 2 versus TIMI flow grade 3 (63% vs. 27%). There was a graded inverse relationship with TIMI flow in the IRA and the adjusted mortality (odds ratio [OR] for TIMI flow grades 0/1: 5.47 [95% confidence interval (CI): 4.13 to 7.24] and for TIMI flow grade 2: 2.63 [95% CI: 2.02 to 3.42] compared with TIMI flow grade 3). Our study also identified factors associated with post-PCI TIMI flow grades 0 to 2.
CONCLUSIONS: Lack of procedural success (post-PCI TIMI flow grades 0 to 2 in the IRA) after primary PCI for STEMI among patients with cardiogenic shock is associated with a much higher risk of mortality compared with the risk for patients with normal post-PCI TIMI flow grade 3.

Entities:  

Mesh:

Year:  2009        PMID: 19463399     DOI: 10.1016/j.jcin.2008.10.006

Source DB:  PubMed          Journal:  JACC Cardiovasc Interv        ISSN: 1936-8798            Impact factor:   11.195


  10 in total

Review 1.  The perils of surrogate endpoints.

Authors:  William S Weintraub; Thomas F Lüscher; Stuart Pocock
Journal:  Eur Heart J       Date:  2015-05-13       Impact factor: 29.983

2.  Clinical characteristics and prognostic factors in acute coronary syndrome patients complicated with cardiogenic shock in Japan: analysis from the Japanese Circulation Society Cardiovascular Shock Registry.

Authors:  Kazuo Sakamoto; Tetsuya Matoba; Masahiro Mohri; Yasushi Ueki; Yasuyuki Tsujita; Masao Yamasaki; Nobuhiro Tanaka; Yohei Hokama; Motoki Fukutomi; Katsutaka Hashiba; Rei Fukuhara; Satoru Suwa; Hirohide Matsuura; Eizo Tachibana; Naohiro Yonemoto; Ken Nagao
Journal:  Heart Vessels       Date:  2019-02-04       Impact factor: 2.037

3.  Usefulness of the RISK-PCI score to predict stent thrombosis in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a substudy of the RISK-PCI trial.

Authors:  Igor Mrdovic; Lidija Savic; Ratko Lasica; Gordana Krljanac; Milika Asanin; Natasa Brdar; Nemanja Djuricic; Natasa Cvetinovic; Jelena Marinkovic; Jovan Perunicic
Journal:  Heart Vessels       Date:  2012-09-14       Impact factor: 2.037

4.  Efficacy and safety of tirofiban-supported primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: results of propensity analysis using the Clinical Center of Serbia STEMI Register.

Authors:  Igor Mrdovic; Lidija Savic; Ratko Lasica; Gordana Krljanac; Milika Asanin; Natasa Brdar; Nemanja Djuricic; Jelena Marinkovic; Jovan Perunicic
Journal:  Eur Heart J Acute Cardiovasc Care       Date:  2013-11-21

5.  Proximal culprit lesion and coronary artery occlusion independently predict the risk of microvascular obstruction in acute myocardial infarction.

Authors:  N Abanador-Kamper; L Kamper; V Karamani; P Haage; M Seyfarth
Journal:  Int J Cardiovasc Imaging       Date:  2016-05-02       Impact factor: 2.357

6.  Circadian Dependence of Infarct Size and Acute Heart Failure in ST Elevation Myocardial Infarction.

Authors:  Aruni Seneviratna; Gek Hsiang Lim; Anju Devi; Leonardo P Carvalho; Terrance Chua; Tian-Hai Koh; Huay-Cheem Tan; David Foo; Khim-Leng Tong; Hean-Yee Ong; A Mark Richards; Chow Khuan Yew; Mark Y Chan
Journal:  PLoS One       Date:  2015-06-03       Impact factor: 3.240

7.  Sex-Specific Treatment Effects After Primary Percutaneous Intervention: A Study on Coronary Blood Flow and Delay to Hospital Presentation.

Authors:  Edina Cenko; Mihaela van der Schaar; Jinsung Yoon; Sasko Kedev; Marija Valvukis; Zorana Vasiljevic; Milika Ašanin; Davor Miličić; Olivia Manfrini; Lina Badimon; Raffaele Bugiardini
Journal:  J Am Heart Assoc       Date:  2019-02-19       Impact factor: 5.501

8.  Factors affecting outcome of primary percutaneous coronary intervention for acute myocardial infarction.

Authors:  Saeid Sadrnia; Masoud Pourmoghaddas; Mahmoud Hadizadeh; Asiyeh Maghamimehr; Masoumeh Esmaeeli; Afshin Amirpour; Alireza Khosravi
Journal:  ARYA Atheroscler       Date:  2013-06

9.  The change in right ventricular systolic function according to the revascularisation method used, following acute ST -segment elevation myocardial infarction.

Authors:  Ilker Gul; Mustafa Zungur; Ahmet Cagri Aykan; Tayyar Gokdeniz; Mustafa Beyazit Alkan; Ahmet Sayin; Aysel Islamli; Murat Bilgin; Ezgi Kalaycioğlu; Turhan Turan
Journal:  Cardiovasc J Afr       Date:  2016 Jan-Feb       Impact factor: 1.167

10.  Gender-related differences in men and women with ST-segment elevation myocardial infarction and incomplete infarct-related artery flow restoration: a multicenter national registry.

Authors:  Małgorzata Zachura; Krzysztof Wilczek; Jacek Kurzawski; Marek Gierlotka; Mariusz Gąsior; Marcin Sadowski
Journal:  Postepy Kardiol Interwencyjnej       Date:  2018-12-11       Impact factor: 1.426

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.